Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

bioAffinity Technologies (BIAF) Other Operating Expenses: 2022-2025

Historic Other Operating Expenses for bioAffinity Technologies (BIAF) over the last 4 years, with Sep 2025 value amounting to $1.2 million.

  • bioAffinity Technologies' Other Operating Expenses fell 29.82% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year decrease of 13.51%. This contributed to the annual value of $6.7 million for FY2024, which is 235.06% up from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Other Operating Expenses is $1.2 million, which was down 4.97% from $1.2 million recorded in Q2 2025.
  • bioAffinity Technologies' 5-year Other Operating Expenses high stood at $1.8 million for Q4 2024, and its period low was -$16,999 during Q4 2022.
  • In the last 3 years, bioAffinity Technologies' Other Operating Expenses had a median value of $1.6 million in 2024 and averaged $1.2 million.
  • The largest annual percentage gain for bioAffinity Technologies' Other Operating Expenses in the last 5 years was 10,351.86% (2023), contrasted with its biggest fall of 62.45% (2023).
  • bioAffinity Technologies' Other Operating Expenses (Quarterly) stood at -$16,999 in 2022, then skyrocketed by 10,351.86% to $1.7 million in 2023, then rose by 3.32% to $1.8 million in 2024, then decreased by 29.82% to $1.2 million in 2025.
  • Its Other Operating Expenses stands at $1.2 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.6 million for Q1 2025.